Specialty Drugs and the Broader Cost Surge in Employer Benefits GLP-1s get the headlines, but theyre part of a broader specialty drug trend thats reshaping employer health care cost trends for 2026 and beyond
Removes dead cells to accelerate skin renewal
The increased inositol-requiring enzyme 1 expression by PFOS, which indicated endoplasmic reticulum (ER) stress activation, was associated with PFOS-mediated autophagy activation that could be attenuated through 4-phenylbutyrate (5 mM, an ER stress inhibitor) and l-Carnitine pretreatment
The confusion behind is AOD-9604 banned searches traces to two separate but often conflated facts: it is prohibited in competitive sport under the World Anti-Doping Agencys Prohibited List (category S2, growth hormone fragments), meaning athletes subject to WADA, USADA, or similar testing cannot use it in any form, and separately, it is not an FDA-approved drug available through any legitimate prescription pathway